|
|
|
Volumn 94, Issue 4 I, 1994, Pages 514-516
|
|
Seroconversion rates to combined measles-mumps-rubella-varicella vaccine of children with upper respiratory tract infection
a
|
|
Author keywords
measles mumps rubella; seroconversion; upper respiratory tract infection; vaccine; varicella vaccine
|
|
Indexed keywords
ANTIBODY;
CHICKENPOX VACCINE;
MEASLES MUMPS RUBELLA VACCINE;
ANTIBODY TITER;
ARTICLE;
CHILD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG MIXTURE;
ENZYME IMMUNOASSAY;
ENZYME LINKED IMMUNOSORBENT ASSAY;
HUMAN;
INFANT;
MAJOR CLINICAL STUDY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SEROCONVERSION;
SUBCUTANEOUS DRUG ADMINISTRATION;
UPPER RESPIRATORY TRACT INFECTION;
ANTIBODIES, VIRAL;
CHICKENPOX VACCINE;
DRUG COMBINATIONS;
HERPESVIRUS 3, HUMAN;
HUMANS;
INFANT;
MEASLES VACCINE;
MEASLES VIRUS;
MEASLES-MUMPS-RUBELLA VACCINE;
MUMPS VACCINE;
MUMPS VIRUS;
PROSPECTIVE STUDIES;
RESPIRATORY TRACT INFECTIONS;
RUBELLA VACCINE;
RUBELLA VIRUS;
TREATMENT FAILURE;
VACCINES, COMBINED;
VIRAL VACCINES;
|
|
EID: 0028070663
PISSN: 00314005
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (50)
|
|
References (0)
|
